16th Annual
T-Cell Lymphoma Forum
March 20-22, 2025
Hilton La Jolla
Torrey Pines, La Jolla, California, USA
Conference rate is $299, reservations must be made by February 18, 2025
The 16th Annual T-Cell Lymphoma Forum has become the premier gathering of experts on T-Cell Lymphoma in the United States and renowned internationally. You won’t want to miss this three-day conference focusing on the exciting new breakthroughs and the very latest information on novel agents and treatment approaches for T-Cell Lymphoma. The Forum provides a composite platform to facilitate progress in TCL research by addressing the hurdles that have confronted oncologists and ultimately paves the way for improved outcomes for patients. The comprehensive agenda includes the most relevant topics that will deepen your understanding of these complex diseases and impact your care of patients.
Target audience:
This course has been designed for all clinicians and scientists with an interest in T-cell Lymphoma, including physicians and other healthcare professionals practicing in hematology, oncology, and related fields.
Topics include:
Epidemiology and Classification
Molecular Biology and Pathogenesis
T-Cell Lymphoma Subtypes
Management and Treatment
Cutaneous T-Cell Lymphoma
International Guidelines
Industry Innovations
For more information:
Call for Abstracts
Abstract Submission is Open!
The planning committee welcomes the submission of abstracts for the 16th Annual T-Cell Lymphoma Forum. Submitted abstracts will be considered for acceptance as a poster presentation, and will also be considered for an oral presentation during the scientific program. Selected posters will be displayed throughout the conference in person and online, and will be highlighted during the “Sushi and Science Poster Session.”
Co-chaired by:
Francine M. Foss, MD
Yale School of Medicine
Won Seog Kim, MD, PhD
Samsung Medical Center
Owen A. O’Connor, MD, PhD
University of Virginia
Joint Accreditation Provider:
